Bayesian Prognostic Covariate Adjustment With Additive Mixture Priors (2310.18027v4)
Abstract: Effective and rapid decision-making from randomized controlled trials (RCTs) requires unbiased and precise treatment effect inferences. Two strategies to address this requirement are to adjust for covariates that are highly correlated with the outcome, and to leverage historical control information via Bayes' theorem. We propose a new Bayesian prognostic covariate adjustment methodology, referred to as Bayesian PROCOVA, that combines these two strategies. Covariate adjustment in Bayesian PROCOVA is based on generative AI algorithms that construct a digital twin generator (DTG) for RCT participants. The DTG is trained on historical control data and yields a digital twin (DT) probability distribution for each RCT participant's outcome under the control treatment. The expectation of the DT distribution, referred to as the prognostic score, defines the covariate for adjustment. Historical control information is leveraged via an additive mixture prior with two components: an informative prior probability distribution specified based on historical control data, and a weakly informative prior distribution. The mixture weight determines the extent to which posterior inferences are drawn from the informative component, versus the weakly informative component. This weight has a prior distribution as well, and so the entire additive mixture prior is completely pre-specifiable without involving any RCT information. We establish an efficient Gibbs algorithm for sampling from the posterior distribution, and derive closed-form expressions for the posterior mean and variance of the treatment effect parameter conditional on the weight, in Bayesian PROCOVA. We evaluate efficiency gains of Bayesian PROCOVA via its bias control and variance reduction compared to frequentist PROCOVA in simulation studies that encompass different discrepancies. These gains translate to smaller RCTs.
- Validation of software for Bayesian models using posterior quantiles. Journal of Computational and Graphical Statistics 15(3), 675–692.
- Avoiding prior–data conflict in regression models via mixture priors. Canadian Journal of Statistics 50(2), 491–510.
- European Medicines Agency (2015). Guideline on Adjustment for Baseline Covariates in Clinical Trials. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-adjustment-baseline-covariates-clinical-trials_en.pdf.
- European Medicines Agency (2022). Qualification Opinion for Prognostic Covariate Adjustment. https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/qualification-opinion-prognostic-covariate-adjustment-procovatm_en.pdf.
- Achieving end-to-end success in the clinic: Pfizer’s learnings on R&D productivity. Drug Discovery Today 27(3), 697–704.
- Medicine needs visionaries. https://unlearnai.substack.com/p/medicine-needs-visionaries.
- Fogel, D. (2018). Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review. Contemp Clin Trials Commun. 11, 156–164.
- Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-use-bayesian-statistics-medical-device-clinical-trials.
- Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products: Guidance for Industry. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/adjusting-covariates-randomized-clinical-trials-drugs-and-biological-products.
- Freedman, D. (1999). From association to causation: Some remarks on the history of statistics. Statistical Science 14(3), 243–258.
- Frieden, T. R. (2017). Evidence for health decision making — beyond randomized, controlled trials. New England Journal of Medicine 377(5), 465–475. PMID: 28767357.
- Bayesian Data Analysis (3 ed.). Chapman and Hall/CRC.
- Stochastic relaxation, gibbs distributions, and the bayesian restoration of images. IEEE Transactions on Pattern Analysis and Machine Intelligence PAMI-6(6), 721–741.
- Covariate-adjusted borrowing of historical control data in randomized clinical trials. Pharmaceutical Statistics 16(4), 296–308.
- Adaptive adjustment of the randomization ratio using historical control data. Clinical Trials 10(3), 430–440.
- Holland, P. W. (1986). Statistics and causal inference. Journal of the American Statistical Association 81(396), 945–960.
- Imbens, G. W. and D. B. Rubin (2015). Causal Inference for Statistics, Social, and Biomedical Sciences: An Introduction (1 ed.). Cambridge University Press.
- Bayesian methods in human drug and biological products development in CDER and CBER. Therapeutic Innovation & Regulatory Science 57(3), 436–444.
- Bayesian hierarchical modeling based on multisource exchangeability. Biostatistics 19(2), 169–184.
- A tutorial on modern Bayesian methods in clinical trials. Therapeutic Innovation & Regulatory Science 57(3), 402–416.
- Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine 383(27), 2603–2615. PMID: 33301246.
- Resurrecting weighted least squares. Journal of Econometrics 197(1), 1–19.
- Rosenbaum, P. and D. B. Rubin (1983). The central role of the propensity score in observational studies for causal effects. Biometrika 70, 41–55.
- Rubin, D. B. (1974). Estimating causal effects of treatments in randomized and nonrandomized studies. Journal of Educational Psychology 66(5), 688–701.
- Rubin, D. B. (1978). Bayesian Inference for Causal Effects: The Role of Randomization. The Annals of Statistics 6(1), 34–58.
- Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score. The International Journal of Biostatistics 18(2), 329–356.
- On the Application of Probability Theory to Agricultural Experiments. Essay on Principles. Section 9. Statistical Science 5(4), 465 – 472.
- Subbiah, V. (2023). The next generation of evidence-based medicine. Nature Medicine 29, 49–58.
- Perspectives on informative Bayesian methods in pediatrics. Journal of Biopharmaceutal Statistics 29, 1–14.
- Covariate adjustment for two-sample treatment comparisons in randomized trials: A principled yet flexible approach. Statistics in Medicine 27(23), 4658–4677.
- Bayesian prognostic covariate adjustment. https://arxiv.org/abs/2012.13112.
- White, H. (1980). A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 48(4), 817–838.
- SAM: Self-adapting mixture prior to dynamically borrow information from historical data in clinical trials. Biometrics, 1–32.
- Yule, G. U. (1899). An investigation into the causes of changes in pauperism in England, chiefly during the last two intercensal decades. Journal of the Royal Statistical Society 62, 249–295.
- Modified robust meta-analytic-predictive priors for incorporating historical controls in clinical trials. Statistics in Biopharmaceutical Research, 1–7.
- Alyssa M. Vanderbeek (3 papers)
- Arman Sabbaghi (8 papers)
- Jon R. Walsh (1 paper)
- Charles K. Fisher (20 papers)